Cognitive impairment and PD patients' capacity to consent to research.
about
Capacity issues and decision-making in dementiaCognition in movement disorders: where can we hope to be in ten years?Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting.Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease.The tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease.Cognitive impairment and dementia in Parkinson's disease: practical issues and management.Informed consent procedures with cognitively impaired patients: A review of ethics and best practices.Future needs for informed consent in stem cell clinical trials in neurodegenerative diseases.Informed Consent to Research with Cognitively Impaired Adults: Transdisciplinary Challenges and Opportunities.Research consent capacity varies with executive function and memory in Parkinson's disease.The effects of normal aging on multiple aspects of financial decision-making.Measuring informed consent capacity in an Alzheimer's disease clinical trial.Changes in Cognition and Decision Making Capacity Following Brain Tumour Resection: Illustrated with Two Cases.Self-reported impulsivity in Huntington's disease patients and relationship to executive dysfunction and reward responsiveness.Inhibitory control and traumatic brain injury: The association between executive control processes and social communication deficits.Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.Capacity, Vulnerability, and Informed Consent for Research.Consent Through Rose-Tinted Glasses: The Optimistic Bias in Parkinson's Disease Clinical Trials
P2860
Q28071428-08CD26CB-DE1D-4F41-9E03-F4E8638F83CDQ35211553-DD4C5E80-8630-4672-8A35-6030C8C29AF1Q35641238-2DCCF531-946A-427B-94E3-120E87419A9CQ35674661-93B941D5-D89E-4B3E-A466-148DB98A8C73Q38206495-24011FEC-DFBA-4C04-BD94-FDF3450A2A28Q38206499-953F5875-50F4-4D92-BAC2-037DDD942081Q38371972-1B05A17E-95A3-4270-BF7B-9208F58C2EECQ38717033-69EA0E17-E215-482F-8D44-A8915C677EFAQ39269360-8A380ECE-2179-4AC6-844D-805F1A4E0AC7Q40764719-986849A1-27CB-4AD0-839B-B6E16E98C11DQ41326405-542AECF5-56DA-4663-81B1-51519C0252AAQ42656148-8A6F5EC1-4A88-4506-AD40-52CDDB4A9090Q47141921-C0F7E130-B13A-4932-AAC6-6E615D22177DQ47866936-578DDF73-F221-433C-AAB5-F1DB3B164A96Q48389198-0F90E5F1-6126-4AC7-A3B5-5DBE87A8F3C7Q55451028-C496E03C-9D76-4535-AA9F-7E61BD56EC01Q55458665-0A74CF19-525E-42BF-BFDD-2430960F4A93Q58244085-4F748E09-AF92-476A-B2E1-72458B264EDA
P2860
Cognitive impairment and PD patients' capacity to consent to research.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cognitive impairment and PD patients' capacity to consent to research.
@ast
Cognitive impairment and PD patients' capacity to consent to research.
@en
type
label
Cognitive impairment and PD patients' capacity to consent to research.
@ast
Cognitive impairment and PD patients' capacity to consent to research.
@en
prefLabel
Cognitive impairment and PD patients' capacity to consent to research.
@ast
Cognitive impairment and PD patients' capacity to consent to research.
@en
P2093
P2860
P1433
P1476
Cognitive impairment and PD patients' capacity to consent to research.
@en
P2093
Daniel Weintraub
Elizabeth Sullo
Sharon Xie
Stephen T Moelter
P2860
P304
P356
10.1212/WNL.0B013E3182A05BA5
P407
P577
2013-07-26T00:00:00Z